BetaTec Hop Products, Inc. – Trademark Portfolio
Entity Type: 03
BetaTec Hop Products, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include LUPUHOP. The owner is based in Washington, DC.
5185 MacArthur Blvd NW, Suite 300
Washington, DC 20016
Showing of trademarks Trademarks
Trademark Classifications
BetaTec Hop Products, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does BetaTec Hop Products, Inc. have?
BetaTec Hop Products, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does BetaTec Hop Products, Inc. file in?
BetaTec Hop Products, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BetaTec Hop Products, Inc.'s most well-known trademarks?
BetaTec Hop Products, Inc.'s registered trademark portfolio includes well-known marks such as LUPUHOP. These are among 1 currently registered trademark in the portfolio.
What is BetaTec Hop Products, Inc.'s trademark registration success rate?
BetaTec Hop Products, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.